Published in Medical Letter on the CDC and FDA, January 15th, 2006
The reductions will affect both the research and development and the general and administrative areas of the company.
Prior to the initial announcement on November 23, 2005 of the company's intention to reduce its workforce, the company had 93 employees. Following the completion of the reduction, the company expects that it will have approximately 48 employees.
EPIX received the second approvable letter from...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA